Intranasal delivery of stem cells to the brain

Expert Opinion on Drug Delivery

Volumn 8, Issue 5, 2011, Pages 623-632

  Jiang, Yongjun ^a   Zhu, Juehua ^a   Xu, Gelin ^a   Liu, Xinfeng ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

brain blood barrier; intranasal; neurological diseases; stem cells; stroke

Indexed keywords

INSULIN; MELANOCORTIN; VASOPRESSIN;

ANATOMY; BLOOD BRAIN BARRIER; BRAIN HYPOXIA; BRAIN ISCHEMIA; BRAIN TUMOR; CELL FATE; CELL THERAPY; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; DEGENERATIVE DISEASE; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; HISTOLOGY; HUMAN; INTRANASAL DRUG DELIVERY; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NONHUMAN; NOSE CAVITY; NOSE MUCOSA; PHYSIOLOGY; REVIEW; STEM CELL TRANSPLANTATION; TRAUMATIC BRAIN INJURY;

ADMINISTRATION, INTRANASAL; BRAIN; CLINICAL TRIALS AS TOPIC; GENE THERAPY; GENETIC VECTORS; HUMANS; NERVOUS SYSTEM DISEASES; NEURAL STEM CELLS; NOSE; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 79955122693     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425247.2011.566267     Document Type: Review

References (81)

1. Jin K, Mao X, Xie L, et al. Transplantation of human neural precursor cells in matrigel scaffolding improves outcome from focal cerebral ischemia after delayed postischemic treatment in rats. J Cereb Blood Flow Metab 2010;30:534-44
2. Harting MT, Sloan LE, Jimenez F, et al. Subacute neural stem cell therapy for traumatic brain injury. J Surg Res 2009;153:188-94
3. Courtois ET, Castillo CG, Seiz EG, et al. In vitro and in vivo enhanced generation of human a9 dopamine neurons from neural stem cells by bcl-xl. J Biol Chem 2010;285:9881-97
4. Deda H, Inci MC, Kurekci AE, et al. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up. Cytotherapy 2009;11:18-25
5. Aharonowiz M, Einstein O, Fainstein N, et al. Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis. PLoS One 2008;3:e3145
6. Yang J, Yan Y, Ciric B, et al. Evaluation of bone marrow- and brain-derived neural stem cells in therapy of central nervous system autoimmunity. Am J Pathol 2010;177:1989-2001
7. Blurton-Jones M, Kitazawa M, Martinez-Coria H, et al. Neural stem cells improve cognition via bdnf in a transgenic model of alzheimer disease. Proc Natl Acad Sci USA 2009;106:13594-9
8. Gogel S, Gubernator M, Minger SL. Progress and prospects: stem cells and neurological diseases. Gene Ther 2011;18(1):1-6
9. Burt RK, Loh Y, Cohen B, et al. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase i/ii study. Lancet Neurol 2009;8:244-53
10. Fisher M, Feuerstein G, Howells DW, et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 2009;40:2244-50
11. Ma YP, Ma MM, Ge S, et al. Intranasally delivered tgf-beta1 enters brain and regulates gene expressions of its receptors in rats. Brain Res Bull 2007;74:271-7 (Pubitemid 47285524)
12. Alcala-Barraza SR, Lee MS, Hanson LR, et al. Intranasal delivery of neurotrophic factors bdnf, cntf, epo, and nt-4 to the cns. J Drug Target 2010;18:179-90
13. Hashizume R, Ozawa T, Gryaznov SM, et al. New therapeutic approach for brain tumors: intranasal delivery of telomerase inhibitor grn163. Neuro Oncol 2008;10:112-20
14. Perl DP, Good PF. Uptake of aluminium into central nervous system along nasal-olfactory pathways. Lancet 1987;1:1028 (Pubitemid 17057868)
15. Bondier JR, Michel G, Propper A, et al. Harmful effects of cadmium on olfactory system in mice. Inhal Toxicol 2008;20:1169-77
16. Broberg EK, Peltoniemi J, Nygardas M, et al. Spread and replication of and immune response to gamma134.5- negative herpes simplex virus type 1 vectors in balb/c mice. J Virol 2004;78:13139-52 (Pubitemid 39507821)
17. Han IK, Kim MY, Byun HM, et al. Enhanced brain targeting efficiency of intranasally administered plasmid DNA: an alternative route for brain gene therapy. J Mol Med 2007;85:75-83 (Pubitemid 46020944)
18. Bitko V, Barik S. Nasal delivery of sirna. Methods Mol Biol 2008;442:75-82
19. Frenkel D, Solomon B. Filamentous phage as vector-mediated antibody delivery to the brain. Proc Natl Acad Sci USA 2002;99:5675-9 (Pubitemid 34411609)
20. Dhuria SV, Hanson LR, Frey WH II. Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci 2010;99:1654-73
21. Jiang Y, Wei N, Lu T, et al. Intranasal brain-derived neurotrophic factor protects brain from ischemic insult via modulating local inflammation in rats. Neuroscience 2011;172:398-405
22. De Rosa R, Garcia AA, Braschi C, et al. Intranasal administration of nerve growth factor (ngf) rescues recognition memory deficits in ad11 anti-ngf transgenic mice. Proc Natl Acad Sci USA 2005;102:3811-16 (Pubitemid 40360709)
23. Wei N, Liu XF, Chau M, et al. Intranasal delivery of bone marrow stem cells into the cerebral ischemic lesion of mice. Program no. 57.10/t5. Neuroscience Meeting Planner. San Diego, CA: Society for Neuroscience, 2010, Available at: http://www. abstractsonline.com/Plan/SSResults.aspx
24. Danielyan L, Schafer R, von Ameln-Mayerhofer A, et al. Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of parkinson disease. Rejuvenation Res 2011;14:3-16
25. Danielyan L, Schafer R, von Ameln-Mayerhofer A, et al. Intranasal delivery of cells to the brain. Eur J Cell Biol 2009;88:315-24
26. Aubry L, Bugi A, Lefort N, et al. Striatal progenitors derived from human es cells mature into darpp32 neurons in vitro and in quinolinic acid-lesioned rats. Proc Natl Acad Sci USA 2008;105:16707-12
27. Deng J, Petersen BE, Steindler DA, et al. Mesenchymal stem cells spontaneously express neural proteins in culture and are neurogenic after transplantation. Stem Cells 2006;24:1054-64 (Pubitemid 44464738)
28. Windrem MS, Nunes MC, Rashbaum WK, et al. Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nat Med 2004;10:93-7 (Pubitemid 38524704)
29. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-72 (Pubitemid 350138099)
30. Vierbuchen T, Ostermeier A, Pang ZP, et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010;463:1035-41
31. Lloyd-Jones D, Adams RJ, Brown TM, et al. Executive summary: heart disease and stroke statistics-2010 update: a report from the american heart association. Circulation 2010;121:948-54
32. Lee HJ, Lim IJ, Lee MC, et al. Human neural stem cells genetically modified to overexpress brain-derived neurotrophic factor promote functional recovery and neuroprotection in a mouse stroke model. J Neurosci Res 2010;88:3282-94
33. Gao J, Prough DS, McAdoo DJ, et al. Transplantation of primed human fetal neural stem cells improves cognitive function in rats after traumatic brain injury. Exp Neurol 2006;201:281-92 (Pubitemid 44344239)
34. Hawkes N. Tracing Burts descent to scientific fraud. Science 1979;205:673-5
35. Einstein O, Friedman-Levi Y, Grigoriadis N, et al. Transplanted neural precursors enhance host brain-derived myelin regeneration. J Neurosci 2009;29:15694-702
36. Brazzini A, Cantella R, De la Cruz A, et al. Intraarterial autologous implantation of adult stem cells for patients with parkinson disease. J Vasc Interv Radiol 2010;21:443-51
37. Walczak P, Zhang J, Gilad AA, et al. Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke 2008;39:1569-74
38. Tolar J, Oshaughnessy M J, Panoskaltsis-Mortari A, et al. Host factors that impact the biodistribution and persistence of multipotent adult progenitor cells. Blood 2006;107:4182-8 (Pubitemid 43726831)
39. Lee JS, Hong JM, Moon GJ, et al. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 2010;28:1099-106
40. Pendharkar AV, Chua JY, Andres RH, et al. Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia. Stroke 2010;41:2064-70
41. Walker PA, Harting MT, Jimenez F, et al. Direct intrathecal implantation of mesenchymal stromal cells leads to enhanced neuroprotection via an nfkappab-mediated increase in interleukin-6 production. Stem Cells Dev 2010;19:867-76
42. Ellenby MS, Tegtmeyer K, Lai S, et al. Lumbar puncture. N Engl J Med 2006;355:e12
43. Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008;57:178-201
44. Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2005;2:3-14 (Pubitemid 40128022)
45. Dahl R, Mygind N. Anatomy, physiology and function of the nasal cavities in health and disease. Adv Drug Deliv Rev 1998;29:3-12 (Pubitemid 28044084)
46. Pires A, Fortuna A, Alves G, et al. Intranasal drug delivery: how, why and what for? J Pharm Pharm Sci 2009;12:288-311
47. Chinese Pharmacopoeia. Chemical Industry Press, Beijing; 2005
48. Frey WH. Neurologic agents for nasal administration to the brain. Chiron Corp., US; 1991
49. van Velthoven CT, Kavelaars A, van Bel F, et al. Nasal administration of stem cells: a promising novel route to treat neonatal ischemic brain damage. Pediatr Res 2010;68:419-22
50. Feifel D, Macdonald K, Nguyen A, et al. Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients. Biol Psychiatry 2010;68:678-80
51. Guastella AJ, Einfeld SL, Gray KM, et al. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biol Psychiatry 2010;67:692-4
52. Born J, Lange T, Kern W, et al. Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci 2002;5:514-16 (Pubitemid 34568991)
53. Benedict C, Hallschmid M, Hatke A, et al. Intranasal insulin improves memory in humans. Psychoneuroendocrinology 2004;29:1326-34 (Pubitemid 39024358)
54. Benedict C, Hallschmid M, Schultes B, et al. Intranasal insulin to improve memory function in humans. Neuroendocrinology 2007;86:136-42 (Pubitemid 47494214)
55. Reger MA, Watson GS, Frey WH II, et al. Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by apoe genotype. Neurobiol Aging 2006;27:451-8 (Pubitemid 43185331)
56. Reger MA, Watson GS, Green PS, et al. Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. J Alzheimers Dis 2008;13:323-31 (Pubitemid 352039034)
57. Reger MA, Watson GS, Green PS, et al. Intranasal insulin improves cognition and modulates beta-amyloid in early ad. Neurology 2008;70:440-8
58. Banks WA, During MJ, Niehoff ML. Brain uptake of the glucagon-like peptide-1 antagonist exendin(9-39) after intranasal administration. J Pharmacol Exp Ther 2004;309:469-75 (Pubitemid 38542596)
59. Jansson B, Bjork E. Visualization of in vivo olfactory uptake and transfer using fluorescein dextran. J Drug Target 2002;10:379-86
60. Dhuria SV, Hanson LR, Frey WH II. Novel vasoconstrictor formulation to enhance intranasal targeting of neuropeptide therapeutics to the central nervous system. J Pharmacol Exp Ther 2009;328:312-20
61. Thorne RG, Pronk GJ, Padmanabhan V, et al. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience 2004;127:481-96 (Pubitemid 38950662)
62. Mitchell FL, Marks GE, Bichenkova EV, et al. Molecular probes: Insights into design and analysis from computational and physical chemistry. Biochem Soc Trans 2008;36:46-50 (Pubitemid 351269619)
63. Hadaczek P, Yamashita Y, Mirek H, et al. The perivascular pump driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain. Mol Ther 2006;14:69-78 (Pubitemid 43922142)
64. Skipor J, Grzegorzewski W, Einer-Jensen N, et al. Local vascular pathway for progesterone transfer to the brain after nasal administration in gilts. Reprod Biol 2003;3:143-59
65. Liu XF, Fawcett JR, Thorne RG, et al. Intranasal administration of insulin-like growth factor-i bypasses the blood-brain barrier and protects against focal cerebral ischemic damage. J Neurol Sci 2001;187:91-7 (Pubitemid 32618661)
66. Florence K, Manisha L, Kumar BA, et al. Intranasal clobazam delivery in the treatment of status epilepticus. J Pharm Sci 2011;100:692-703
67. Shingaki T, Inoue D, Furubayashi T, et al. Transnasal delivery of methotrexate to brain tumors in rats: a new strategy for brain tumor chemotherapy. Mol Pharm 6 August 2010. [Epub ahead of print] doi:10.1021/mp900275s
68. Martinez JA, Francis GJ, Liu WQ, et al. Intranasal delivery of insulin and a nitric oxide synthase inhibitor in an experimental model of amyotrophic lateral sclerosis. Neuroscience 2008;157:908-25
69. Yuki Y, Byun Y, Fujita M, et al. Production of a recombinant hybrid molecule of cholera toxin-b-subunit and proteolipid-protein-peptide for the treatment of experimental encephalomyelitis. Biotechnol Bioeng 2001;74:62-9 (Pubitemid 32606595)
70. Piao HM, Balakrishnan P, Cho HJ, et al. Preparation and evaluation of fexofenadine microemulsion for intranasal delivery. Int J Pharm 2010;395:309-16
71. Dalpiaz A, Gavini E, Colombo G, et al. Brain uptake of an anti-ischemic agent by nasal administration of microparticles. J Pharm Sci 2008;97:4889-903
72. Cheng S, Ma M, Ma Y, et al.combination therapy with intranasal ngf and electroacupuncture enhanced cell proliferation and survival in rats after stroke. Neurol Res 2009;31:753-8
73. Steyn D, du Plessis L, Kotze A. Nasal delivery of recombinant human growth hormone: in vivo evaluation with pheroid technology and n-trimethyl chitosan chloride. J Pharm Pharm Sci 2010;13:263-73
74. van den Berg MP, Romeijn SG, Verhoef JC, et al. Serial cerebrospinal fluid sampling in a rat model to study drug uptake from the nasal cavity. J Neurosci Methods 2002;116:99-107 (Pubitemid 34465788)
75. Zwijnenburg PJ, van der Poll T, Florquin S, et al. Experimental pneumococcal meningitis in mice: a model of intranasal infection. J Infect Dis 2001;183:1143-6 (Pubitemid 32230968)
76. Yasuhara T, Hara K, Maki M, et al. Intravenous grafts recapitulate the neurorestoration afforded by intracerebrally delivered multipotent adult progenitor cells in neonatal hypoxic-ischemic rats. J Cereb Blood Flow Metab 2008;28:1804-10
77. Bovetti S, Hsieh YC, Bovolin P, et al. Blood vessels form a scaffold for neuroblast migration in the adult olfactory bulb. J Neurosci 2007;27:5976-80 (Pubitemid 46849744)
78. Lois C, Garcia-Verdugo JM, Alvarez-Buylla A. Chain migration of neuronal precursors. Science 1996;271:978-81 (Pubitemid 26066393)
79. Moore BE, Colvin GA, Dooner MS, et al. Lineage-negative bone marrow cells travel bidirectionally in the olfactory migratory stream but maintain hematopoietic phenotype. J Cell Physiol 2005;202:147-52 (Pubitemid 39603371)
80. Ferriero DM. Neonatal brain injury. N Engl J Med 2004;351:1985-95
81. Willenberg BJ, Zheng T, Meng FW, et al. Gelatinized copper-capillary alginate gel functions as an injectable tissue scaffolding system for stem cell transplants. J Biomater Sci Polym Ed 9 August 2010. [Epub ahead of print] doi:10.1163/092050610X519453